- Home
- KROS vs VLGEA Comparison
KROS vs VLGEA Comparison
Compare KROS & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | VLGEA |
|---|---|---|
| Founded | 2015 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 556.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KROS | VLGEA |
|---|---|---|
| Price | $17.80 | $34.33 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $22.20 | N/A |
| AVG Volume (30 Days) | ★ 597.1K | 42.4K |
| Earning Date | 02-25-2026 | 12-02-2025 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | N/A | ★ 7.88 |
| EPS | 1.57 | ★ 3.75 |
| Revenue | $246,718,000.00 | ★ $2,345,586,000.00 |
| Revenue This Year | $6,924.79 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.38 | ★ $9.19 |
| Revenue Growth | ★ 37798.31 | 3.88 |
| 52 Week Low | $9.12 | $29.64 |
| 52 Week High | $22.55 | $40.15 |
Technical Indicators
Market Signals| Indicator | KROS | VLGEA |
|---|---|---|
| Relative Strength Index (RSI) | 35.45 | 39.70 |
| Support Level | $19.76 | $33.75 |
| Resistance Level | $21.76 | $36.56 |
| Average True Range (ATR) | 0.81 | 1.07 |
| MACD | -0.54 | -0.43 |
| Stochastic Oscillator | 5.18 | 11.49 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.